Covid vaccines that have been updated to protect people against hospitalization and death from the Omicron variant of the virus are expected to be approved by the end of the month.
VACCINE
Covid vaccines that have been updated to protect people against hospitalization and death from the Omicron variant of the virus are expected to receive approval by the end of the month.
The European Medicines Agency (EMA) is recommending Novavax’s Covid-19 vaccine carry a warning of two types of heart inflammation, based on a small number of reported cases, an added burden for a shot that has failed to win wide uptake.
A European health emergency official on Wednesday said adapted versions of established mRNA Covid-19 vaccines that address two variants in one shot will soon offer people better protection than vaccines that are now available.
European Union health agencies on Monday recommended a second Covid-19 booster for everyone above 60 amid a new rise in infections and hospitalisations across Europe.
The European Medicines Agency (EMA) is open to different next generation Covid vaccines, an official said on Thursday, amid a rise in cases due to circulating Omicron offshoots.
A strong recommendation for a fourth dose of coronavirus vaccine for people aged over 60 with underlying conditions was reiterated on Thursday by National Vaccination Committee President Maria Theodoridou and General Secretary of Primary Healthcare Marios Themistokleous.
In contrast to the speed with which we took up the previous doses of the vaccine against SARS-CoV-2, Greeks are hesitating over the fourth dose.
The platform to book an appointment for the fourth dose against Covid-19 opened on Monday for the age group 30-59 years of age.
The National Vaccination Committee recommended that a second Covid booster shot be available to everyone over 30 after convening on Thursday. It was stressed that this second booster shot is not yet mandatory, just a recommendation.
European Union governments are intensifying pressure on Pfizer and other Covid-19 vaccine makers to renegotiate contracts, warning millions of shots that are no longer needed could go to waste, according to EU officials and a document.
Greek health authorities are awaiting recommendations from European authorities regarding the strategy to follow regarding the use of vaccines against smallpox, which seem to provide some protection against monkeypox.
Drugmaker AstraZeneca said on Monday its Covid-19 vaccine, Vaxzevria, has been approved in the European Union by the bloc’s drugs regulator as a third-dose booster in adults following a committee endorsement last week.
Greek teenagers who require a booster vaccination shot in order to attend educational programs in other countries will be able to receive one, following a decision by the National Vaccination Committee.
The European Commission said on Monday that no final decision had been made about the possible termination of a contract with Valneva to supply its Covid-19 vaccine to the European Union.
A decision on whether to lift indoor masking mandates will be made on June 1 depending on Covid-19 burden, Health Minister Thanos Plevris told Skai radio on Wednesday.
[nx_login_form]x
